ConductScience.org, home

Paper90689

Determination of thyroid stimulating immunoglobulins (TSI) during the course of Graves' disease. A reliable indicator for remission and persistence of this disease?

Schleusener H and 5 others. J Endocrinol Invest, 1978. Cited by 25 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Determination of thyroid stimulating immunoglobulins (TSI) during the course of Graves' disease. A reliable indicator for remission and persistence of this disease? Papers, record 90689. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/90689

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Determination of thyroid stimulating immunoglobulins (TSI) during the course of Graves' disease. A reliable indicator for remission and persistence of this disease?
PubMed
Journal
J Endocrinol Invest
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
25
iCite
Relative citation ratio, by iCite
1.16
iCite
Revised in PubMed
2018-11-13
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Schleusener HH
2Finke RR
3Kotulla PP
4Wenzel KWK W
5Meinhold HH
6Roedler HDH D

Source PubMed

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antithyroid AgentsMajor topic
Graves DiseaseMajor topic
Immunoglobulin GMajor topic
Humans
Radioligand Assay
Recurrence
Thyroid Function Tests
Thyrotropin

Source PubMed

References16

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14,368,451Binding of thyroid stimulators to thyroid membranes.FEBS Lett1974https://conductscience.org/library/papers/4368451PubMed
2821,961Thyroid-stimulating immunoglobulins and the control of thyroid function.J Clin Endocrinol Metab1976https://conductscience.org/library/papers/821961PubMed
31,242,809Long-acting thyroid stimulator and related factors.Proc R Soc Med1975https://conductscience.org/library/papers/1242809PubMed
469,269Short-term antithyroid drug therapy for the thyrotoxicosis of Graves's disease.N Engl J Med1977https://conductscience.org/library/papers/69269PubMed
54,823,927Evidence of lower toxicity during thyroxine suppression after a single 3-mg L-thyroxine dose: comparison to the classical L-triiodothyronine test for thyroid suppressibility.J Clin Endocrinol Metab1974https://conductscience.org/library/papers/4823927PubMed
64,801,124Sequential assessment during drug treatment of thyrotoxicosis.Clin Endocrinol (Oxf)1973https://conductscience.org/library/papers/4801124PubMed
74,432,950Quantitative thyroid scanning: a reliable thyroid function test.Am J Roentgenol Radium Ther Nucl Med1974https://conductscience.org/library/papers/4432950PubMed
868,278Value of thyroid-stimulating-antibody determinations in predicting short-term thyrotoxic relapse in Graves' disease.Lancet1977https://conductscience.org/library/papers/68278PubMed
94,601,273The pathogenesis of Graves' disease and Hashimoto's thyroiditis.Clin Endocrinol (Oxf)1974https://conductscience.org/library/papers/4601273PubMed
1047,482Relation of thyroid-stimulating immunoglobulins to thyroid function and effects of surgery, radioiodine, and antithyroid drugs.Lancet1975https://conductscience.org/library/papers/47482PubMed
115,109,861Measurements by competitive binding radioassay of serum anti-microsomal and anti-thyroglobulin antibodies in Graves' disease and other thyroid disorders.J Clin Endocrinol Metab1971https://conductscience.org/library/papers/5109861PubMed
1250,946[Controlled therapy of hyperthyroidism].Ergeb Inn Med Kinderheilkd1975https://conductscience.org/library/papers/50946PubMed
134,212,870[TRH stimulation test with age and sex specific TSH response in normal subjects (authors' transl)].Klin Wochenschr1974https://conductscience.org/library/papers/4212870PubMed
154,406,686Correlation between long-acting thyroid stimulator protector level and thyroid 131-I uptake in thyrotoxicosis.Br Med J1974https://conductscience.org/library/papers/4406686PubMed
16177,449A reconsideration of a thyroid-stimulating immunoglobulin as the cause of hyperthyroidism in Graves' disease.J Clin Endocrinol Metab1976https://conductscience.org/library/papers/177449PubMed
17576,175Identification of subgroups of euthyroid graves's ophthalmopathy.N Engl J Med1977https://conductscience.org/library/papers/576175PubMed

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.

PMIDTitleJournalYearIn PapersSource
6,896,520Changes of circulating thyroid autoantibody levels during and after the therapy with methimazole in patients with Graves' disease.J Endocrinol Invest1982https://conductscience.org/library/papers/6896520PubMed
6,147,37710 years experience with consecutive measurement of thyrotropin binding inhibiting antibodies (TBIAb).J Endocrinol Invest1984https://conductscience.org/library/papers/6147377PubMed
6,139,399
The prognostic value of parallel measurements of thyrotropin binding inhibiting immunoglobulins (TBII) and thyroid adenylate cyclase stimulating antibodies (TSAb) in Graves' disease after longterm antithyroid treatment.
J Endocrinol Invest1983https://conductscience.org/library/papers/6139399PubMed
2,879,958Thyroid-stimulating antibodies in patients with long-term remission of Graves' hyperthyroidism.Klin Wochenschr1986https://conductscience.org/library/papers/2879958PubMed
2,868,149Prognostic value of thyroid stimulating antibodies and TSH-binding inhibiting immunoglobulins in the follow-up of Graves' disease.Klin Wochenschr1985https://conductscience.org/library/papers/2868149PubMed
2,573,625Thyroglobulin, thyrotropin and thyrotropin binding inhibiting immunoglobulins assayed at the withdrawal of antithyroid drug therapy as predictors of relapse of Graves' disease within one year.J Endocrinol Invest1989https://conductscience.org/library/papers/2573625PubMed
2,421,862Clinical applications of assays for thyrotropin-receptor antibodies in Graves' disease.CMAJ1986https://conductscience.org/library/papers/2421862PubMed
1,357,830Clinical course and thyroid stimulating hormone (TSH) receptor antibodies during surgical treatment of Graves' disease.World J Surg1992https://conductscience.org/library/papers/1357830PubMed
582,828Interference of thyroglobulin in TSab detection by radio-receptor assay.J Endocrinol Invest1979https://conductscience.org/library/papers/582828PubMed
581,653Successful treatment of exophthalmos and pretibial myxoedema with plasmapheresis.Br Med J1979https://conductscience.org/library/papers/581653PubMed
381,768[Cell receptor defects as the cause of endocrine and metabolic diseases (author's transl)].Klin Wochenschr1979https://conductscience.org/library/papers/381768PubMed
227,717TSH-receptor antibodies, HLA B8 and thyroid autoantibodies in patients with Graves' disease in therapeutically induced euthyroidism.Experientia1979https://conductscience.org/library/papers/227717PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/90689

GET https://conductscience.org/api/papers/v1/90689/authors